Item 8.01 Other Events
On September 26, 2022, DURECT Corporation issued a press release announcing that
POSIMIR® (bupivacaine solution) is now commercially available in the U.S. for
the treatment of post-surgical pain in adults following arthroscopic subacromial
decompression surgery. A copy of the press release is attached as Exhibit 99.1
to this Form 8-K and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release of DURECT Corporation dated September 26, 20 22
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
3
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses